Korea FilingsFull brief — $39

HANDOK Inc.

(주)한독 · KOSPI: 002390 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
(주)한독
Market / ticker
KOSPI · 002390
Industry
Pharmaceuticals and medicinal chemicals
Established
1954-07-01
Fiscal year ends
December
Website
www.handok.co.kr
DART corp code
00161046
Latest revenue
₩535.1B (FY2025)

Items worth checking

low
Conversion / warrant / exchange rights exercised — shares outstanding change — filed on 3 separate dates in the last 12 months, latest 2026-08-13.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩522.7B₩507.4B₩535.1B
Operating income₩12.6B₩539M₩3.3B
Net income−₩28.9B−₩52.7B−₩2.2B
Total assets₩790.3B₩788.6B₩790.8B
Total liabilities₩449.7B₩499.5B₩512.4B
Total equity₩340.6B₩289.1B₩278.3B
Share capital₩6.9B₩6.9B₩6.9B

Consolidated statements · FY2025 operating margin 0.6% · liabilities to equity 184% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 68 (current)삼정회계법인Unqualified
Term 67 (prior)삼정회계법인Unqualified
Term 66 (two years prior)삼정회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-09-10Amended: Large shareholding (5%+) reportDART
2026-09-10Amended: Large shareholding (5%+) reportDART
2026-09-10Large shareholding (5%+) reportDART
2026-08-20Large shareholding (5%+) reportDART
2026-08-14Half-year report (2026.06)DART
2026-08-13Adjustment of conversion / exercise / exchange price (notice)DART
2026-07-30Preliminary operating results (fair disclosure)DART
2026-07-20Large shareholding (5%+) reportDART
2026-07-20Change in shareholdings of largest shareholderDART
2026-07-20Large shareholding (5%+) reportDART
2026-07-20Change in shareholdings of largest shareholderDART
2026-07-15Fair trade compliance program status (notice)DART
2026-07-10Amended: Stock option grantDART
2026-07-10Stock option grantDART
2026-06-18Large shareholding (5%+) reportDART
2026-06-12Large shareholding (5%+) reportDART
2026-06-04Large shareholding (5%+) reportDART
2026-06-04Officer / major shareholder ownership reportDART
2026-06-02Change in shareholdings of largest shareholderDART
2026-06-01Corporate governance reportDART

Showing the 20 most recent of 64 filings. The full brief lists all of them.

Full brief on HANDOK Inc. — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.